Prevalence of Rho-inactivating epidermal cell differentiation inhibitor toxins in clinical Staphylococcus aureus isolates

Citation
A. Czech et al., Prevalence of Rho-inactivating epidermal cell differentiation inhibitor toxins in clinical Staphylococcus aureus isolates, J INFEC DIS, 184(6), 2001, pp. 785-788
Citations number
12
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
184
Issue
6
Year of publication
2001
Pages
785 - 788
Database
ISI
SICI code
0022-1899(20010915)184:6<785:PORECD>2.0.ZU;2-J
Abstract
Staphylococcus aureus produces exotoxins of the epidermal cell differentiat ion inhibitor (EDIN) family that ADP-ribosylate and inactivate Rho GTPases. The prevalence of genes encoding EDIN in clinical and nasal isolates of S. aureus was investigated. Of the 196 clinical S. aureus isolates tested, 15 (7.8%) were positive for 1 edin gene, whereas of 81 nasal isolates tested, only 3 (3.7%) were edin positive. Of the total 18 edin-positive isolates, 16 (90%) carried edin-B and 2 (10%) carried edin-C, but none was positive f or edin-A. All edin-positive strains could produce the respective EDIN prot ein. Pulsed-field gel electrophoresis analysis suggested that the edin-B-po sitive S. aureus isolates are derived from one clone, and the edin-C-positi ve isolates are derived from another clone. Given that toxins acting on Rho GTPases are considered to be important for bacterial virulence, the EDIN t oxins of S. aureus should receive more attention in future studies.